netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Emerging Vision Scientists Visit Capitol Hill

On September 15, the National Alliance for Eye and Vision Research (NAEVR) held its Advocacy Day, supported by Research to Prevent Blindness (RPB), in which 22 emerging vision scientists conducted 50 Capitol Hill visits to discuss their work and champion the need for continued federal funding for critical vision research.

Emerging vision scientists visit the office of Senator Kirsten Gillibrand

Emerging vision scientists and RPB visit the office of Senator Kirsten Gillibrand 

NAEVR's message that "research does not have a pause button" was well received by congressional staff and the eight members of Congress who met directly with the emerging vision scientists. RPB President Brian Hofland, PhD, accompanied several of the emerging vision scientists on their visits with congressional staff, and stressed the need to fund young researchers through both foundations and non-profits (such as RPB) and federal grants.

The young researchers appreciated the opportunity to speak about their work in a political forum. "Personally, I was quite enlightened by these visits in gaining an understanding of the nuts and bolts of how science policy and funding decisions are made at the government level. I feel that this experience helped me to better develop skills to 'sell research' to non-scientists who play a critical role in funding vision research," said Daniel Chao, MD, PhD, from the University of California San Diego.

Emerging vision scientists at AVER Congressional reception

Emerging vision scientists attend the AVER Congressional reception 

Prior to going to the Hill, on September 14 the emerging vision scientists displayed posters of their research at an evening Congressional reception hosted by the Alliance for Eye and Vision Research (AVER, which is NAEVR's associated non-profit educational organization) at which National Eye Institute Director Paul Sieving, MD, PhD, spoke and members of Congress has a chance to interact with the young researchers.

On September 28, just weeks after Advocacy Day, Congress passed a short-term Continuing Resolution that funds the government through the end of 2016--one of the requests NAEVR, RPB and the emerging vision scientists made at their visits. They also advocated for Congressional representatives to return following the election in November to complete 2017 appropriations, including a $2 billion National Institutes of Health funding increase to $34.1 billion.

 

 

 

Related News: Top Story

RPB logo

Research to Prevent Blindness Expands Career Development Award

RPB is increasing both the amount of funding and the number of awards funded through its flagship grant in order to better support early-career vision scientists.

Read More

 
RPB logo

Research to Prevent Blindness and Allergan Foundation Announce New Partnership to Support Early-Career Vision Researchers

The organizations announce new grants to increase funding for innovative research from early-career vision scientists.

Read More

 
RPB logo
Watch The Video

Research to Prevent Blindness Celebrates 60th Anniversary

For the past 60 years, RPB has funded groundbreaking research to prevent, treat and cure all conditions that damage or destroy sight.

Read More

 
Letter from NEI

National Eye Institute Recognizes RPB's 60th Anniversary

The NEI congratulates RPB on 60 years of accomplishments in a personal letter from the acting director.

Read More

 
CDA banner art
Watch The Video

In Their Own Words: Why the RPB Career Development Awards Matter

Thank you to our donors for supporting the RPB CDA and launching more than 200 research careers!

Read More

 
Dr. Semenza and colleague work in his lab

Research to Prevent Blindness Grantee Dr. Gregg Semenza Wins Nobel Prize in Medicine

Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.